Interventional studies concerning the role of antioxidant vitamins in cardiovascular diseases: A review

Journal of Nutrition, Health and Aging

Volumn 5, Issue 3, 2001, Pages 188-195

  Czernichow, S ^a   Hercberg, S ^a  

^a INSERM   (France)

Author keywords

Antioxidants; Beta carotene; Cardiovascular diseases; Intervention studies; Prevention; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; FREE RADICAL;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG ACTIVITY; FEEDING BEHAVIOR; HUMAN; PRIORITY JOURNAL; REVIEW; VITAMIN INTAKE;

EID: 0034915818     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. The impending global epidemic of cardiovascular diseases
2. Background and rationale behind the SU.VI.MAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers
3. Lipoproteins and atherogenesis. Current concepts
4. A randomized, single-blind, placebo-controlled trial of the effects of 200 mg alpha-tocopherol on the oxidation resistance of atherogenic lipoproteins
5. β-Carotene inhibits the oxidative modification of low-density lipoprotein
6. Effects of beta-carotene supplementation on lipid peroxidation in humans
7. Beta-carotene's effects on serum lipoproteins and immunologic indices in humans
8. Influence of antioxidant vitamins on LDL oxidation
9. Fruit and vegetable consumption and cardiovascular mortality
10. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer
11. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology
12. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology
13. Relationship of plasma level of vitamin C to mortality from ischemic heart disease
14. The potential role of antioxidant vitamins in preventing cardiovascular diseases and cancers
15. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men
16. Plasma antioxidants and coronary heart disease: Vitamins C and E, and selenium
17. Leukocyte ascorbic acid and its relationship to coronary artery disease in man
18. Antioxidants in adipose tissue and risk of myocardial infarction: The EURAMIC Study
19. Vitamin E consumption and the risk of coronary disease in women
20. Vitamin E consumption and the risk of coronary heart disease in men
21. The role of beta-carotene in the prevention of cardiovascular disease
22. Design of physicians' health study II - A randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials
23. Antioxidants and cardiovascular disease: A review
24. Dietary habits in relation to incidence of cardiovascular disease and death in women: A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden
25. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: A randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis
26. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction?
27. Antioxidants and coronary heart disease
28. Serum selenium, vitamin antioxidants, and cardiovascular mortality: A 9-year follow-up study in the Netherlands
29. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: An epidemiological update with special attention to carotene and vitamin C
30. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
31. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: The established populations for epidemiologic studies of the elderly
32. Vitamin and mineral supplement use and mortality in a US cohort
33. Multivitamin use and mortality in a large prospective study
34. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population
35. The Linxian trials: Mortality rates by vitamin-mineral intervention group
36. Do nutritional supplements lower the risk of stroke or hypertension?
37. Lowered risks of hypertension and cerebrovascular disease after vitamin/mineral supplementation: The linxian nutrition intervention trial
38. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
39. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease
40. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
41. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
42. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: The women's health study
43. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: The SU.VI.MAX study - Design, methods, and participant characteristics
44. Alpha tocopherol in the treatment of intermittent claudication
45. Quantitative evaluation of vitamin E in the treatment of angina pectoris
46. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA)
47. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure
48. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
49. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering
50. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infraction
51. Effects of alpha tocopherol and beta carotene supplements on symptoms, progression, and prognosis of angina pectoris
52. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
53. Vitamin E supplementation and cardiovascular events in high-risk patients
54. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial
55. Dynamics of vitamin E action against LDL oxidation
56. Molecular action of vitamin E in lipoprotein oxidation: Implications for atherosclerosis
57. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers
58. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods